The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol-Reference-Cited by-同舟云学术

The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol

Published:2014-12-05 Issue:1 Volume:4 Page:2-11
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Kempsford Rodger¹,Allen Ann¹,Bareille Philippe¹,Hamilton Melanie²,Cheesbrough Anne³

Affiliation:

1. GlaxoSmithKline; Gunnels Wood Road Stevenage Herts UK

2. GlaxoSmithKline; Ware Hertfordshire UK

3. GlaxoSmithKline; Stockley Park West Uxbridge Middlesex UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.160/fullpdf

Reference38 articles.

1. Global Initiative for Asthma (GINA) 2010 Global Strategy for Asthma Management and Prevention http://www.ginaasthma.org

2. National Heart, Lung and Blood Institute (NHLBI) 2007 National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung and Blood Institute http://www.nhbli.gov

3. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 Global Strategy for Diagnosis, Management and Prevention of COPD http://www.goldcopd.org

4. Indacaterol: a new once-daily long-acting beta2-adrenoreceptor agonist;Beeh;Core Evidence.,2009

5. Emerging inhaled bronchodilators: an update;Cazzola;Eur Respir J.,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic index of inhaled corticosteroids in asthma: A dose–response comparison on airway hyperresponsiveness and adrenal axis suppression;British Journal of Clinical Pharmacology;2020-06-17

2. Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination;Clinical Pharmacology in Drug Development;2016-06-26

3. Fluticasone furoate and vilanterol trifenatate combination therapy for the treatment of asthma;Expert Review of Respiratory Medicine;2016-06-08

4. Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate;Recent Patents on Inflammation & Allergy Drug Discovery;2016-02-11

5. Pharmacodynamics and Pharmacokinetics of Fluticasone Furoate/Vilanterol in Healthy Chinese Subjects;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2015-06